These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24832023)

  • 1. Association of IgG immunoglobulin and subclasses level with the severity of chromoblastomycosis due to Fonsecaea pedrosoi and therapeutic response to itraconazole.
    Azevedo CD; Bruña-Romero O; Marques SG; Nascimento FR; Pinto MC; Silva LA; Bouillet LE; Azevedo FS; Stoianoff MA
    Eur J Clin Microbiol Infect Dis; 2014 Oct; 33(10):1791-7. PubMed ID: 24832023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extensive chromoblastomycosis caused by Fonsecaea pedrosoi successfully treated with a combination of amphotericin B and itraconazole.
    Paniz-Mondolfi AE; Colella MT; Negrín DC; Aranzazu N; Oliver M; Reyes-Jaimes O; Pérez-Alvarez AM
    Med Mycol; 2008 Mar; 46(2):179-84. PubMed ID: 18324498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case Report: A Case of Chromoblastomycosis Caused by Fonsecaea pedrosoi in Vietnam.
    Le TA; Nguyen KL; Pham MH; Vi TT; Do NA
    Mycopathologia; 2019 Feb; 184(1):115-119. PubMed ID: 29974323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment for chromoblastomycosis caused by Fonsecaea monophora: a report of three cases in Guangdong, China.
    Zhang J; Xi L; Lu C; Li X; Xie T; Zhang H; Xie Z; De Hoog S
    Mycoses; 2009 Mar; 52(2):176-81. PubMed ID: 18627476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphangitic chromoblastomycosis.
    Muhammed K; Nandakumar G; Asokan KK; Vimi P
    Indian J Dermatol Venereol Leprol; 2006; 72(6):443-5. PubMed ID: 17179621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An impressive case of chromoblastomycosis due to Fonsecaea pedrosoi in a patient with a long history of fungal infection.
    Romero-Navarrete M; Ruíz LF; Castillo A; Arenas R; Vega-Memije ME; Xicohtencatl-Cortes J; Espinoza-Rivera M; Hernández-Castro R
    J Mycol Med; 2018 Dec; 28(4):663-665. PubMed ID: 30126716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromoblastomycosis caused by Fonsecaea: clinicopathology, susceptibility and molecular identification of seven consecutive cases in Southern China.
    Yang YP; Li W; Huang WM; Zhou Y; Fan YM
    Clin Microbiol Infect; 2013 Nov; 19(11):1023-8. PubMed ID: 23153454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoprecipitation techniques and Elisa in the detection of anti-Fonsecaea pedrosoi antibodies in chromoblastomycosis.
    Vidal MS; de Castro LG; Cavalecate SC; Lacaz Cda S
    Rev Inst Med Trop Sao Paulo; 2003; 45(6):315-8. PubMed ID: 14762630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Itraconazole in the treatment of chromoblastomycosis due to Fonsecaea pedrosoi.
    Queiroz-Telles F; Purim KS; Fillus JN; Bordignon GF; Lameira RP; Van Cutsem J; Cauwenbergh G
    Int J Dermatol; 1992 Nov; 31(11):805-12. PubMed ID: 1330949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early immune response against Fonsecaea pedrosoi requires Dectin-2-mediated Th17 activity, whereas Th1 response, aided by Treg cells, is crucial for fungal clearance in later stage of experimental chromoblastomycosis.
    Siqueira IM; Wüthrich M; Li M; Wang H; Las-Casas LO; de Castro RJA; Klein B; Bocca AL
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008386. PubMed ID: 32542003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen distribution and antigen-presenting cells in skin biopsies of human chromoblastomycosis.
    Sotto MN; De Brito T; Silva AM; Vidal M; Castro LG
    J Cutan Pathol; 2004 Jan; 31(1):14-8. PubMed ID: 14675280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromoblastomycosis in the Amazon region, Brazil, caused by Fonsecaea pedrosoi, Fonsecaea nubica, and Rhinocladiella similis: Clinicopathology, susceptibility, and molecular identification.
    de Andrade TS; de Almeida AMZ; Basano SA; Takagi EH; Szeszs MW; Melhem MSC; Albuquerque M; Camargo JSAA; Gambale W; Camargo LMA
    Med Mycol; 2020 Feb; 58(2):172-180. PubMed ID: 31329924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromoblastomycosis: clinical experience and review of literature.
    Queiróz AJR; Pereira Domingos F; Antônio JR
    Int J Dermatol; 2018 Nov; 57(11):1351-1355. PubMed ID: 30113072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic and molecular identification of Fonsecaea pedrosoi strains isolated from chromoblastomycosis patients in Mexico and Venezuela.
    Carolina Rojas O; León-Cachón RB; Pérez-Maya AA; Aguirre-Garza M; Moreno-Treviño MG; González GM
    Mycoses; 2015 May; 58(5):267-72. PubMed ID: 25728464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of chromoblastomycosis due to Fonsecaea pedrosoi by the combination of itraconazole and cryotherapy.
    Kullavanijaya P; Rojanavanich V
    Int J Dermatol; 1995 Nov; 34(11):804-7. PubMed ID: 8543418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An unusual dematiaceous fungal infection of the skin caused by Fonsecaea pedrosoi: a case report and review of the literature.
    Hamza SH; Mercado PJ; Skelton HG; Smith KJ
    J Cutan Pathol; 2003 May; 30(5):340-3. PubMed ID: 12753177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly specific and sensitive, immunoblot-detected 54 kDa antigen from Fonsecaea pedrosoi.
    Vidal MS; Castro LG; Cavalcante SC; Lacaz CS
    Med Mycol; 2004 Dec; 42(6):511-5. PubMed ID: 15682639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of chromoblastomycosis caused by Fonsecaea pedrosoi using imiquimod.
    Belda W; Criado PR; Passero LFD
    J Dermatol; 2020 Apr; 47(4):409-412. PubMed ID: 31960479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromoblastomycosis.
    Torres-Guerrero E; Isa-Isa R; Isa M; Arenas R
    Clin Dermatol; 2012; 30(4):403-8. PubMed ID: 22682188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy combined with terbinafine against chromoblastomycosis and the effect of PDT on Fonsecaea monophora in vitro.
    Hu Y; Huang X; Lu S; Hamblin MR; Mylonakis E; Zhang J; Xi L
    Mycopathologia; 2015 Feb; 179(1-2):103-9. PubMed ID: 25366276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.